| Determination of the association between BDNF, a potential biomarker, and depression in patients with cancer |
Lei Zhang |
Uniformed Services University |
PLCO |
Aug 22, 2022 |
PLCO-1021 |
| Fatty acids intake with emphasis on trans fatty acids and risks of Breast cancer and Colorectal Cancer |
Paolo Boffetta |
The Department of Medical and Surgical Sciences (DIMEC), the University of Bologna |
PLCO |
Aug 22, 2022 |
PLCO-1018 |
| AI cancer detection project |
TAEHEE KIM |
Radisen Co.Ltd. |
PLCO |
Aug 22, 2022 |
PLCOI-1022 |
| Image quality assessment of digitized chest X ray images |
Tomoki Nakamizo |
Radiation Effects Research Foundation |
PLCO |
Aug 4, 2022 |
PLCOI-1017 |
| Bladder Cancer Data Visualization |
OMAR GALDAMEZ CRUZ |
CENTRO DE DISEÑO Y COMUNICACION, S.C. |
PLCO |
Aug 2, 2022 |
PLCO-1011 |
| Prognostic factors in HER2-positive breast cancer |
Reem Chamseddine |
Weill Cornell Medicine-Qatar |
PLCO |
Aug 2, 2022 |
PLCO-1014 |
| Clarifying the relationship between body mass index and lung cancer using causal inference methods |
Rajat Das Gupta |
University of South Carolina |
PLCO |
Aug 2, 2022 |
PLCO-1010 |
| A Phase II extension of the use of cg05575921 Methylation to predict risk for lung cancer |
Robert Philibert |
Behavioral Diagnostics |
PLCO |
Aug 1, 2022 |
2022-0014 |
| Characterization of serum immuno-oncology biomarker levels in PLCO participants with mosaic chromosomal alterations |
Mitchell Machiela |
National Cancer Institute |
PLCO |
Aug 1, 2022 |
2022-0022 |
| Survival Analysis and the Effect of Censoring for Lung Cancer |
Azar Shahraz |
AstraZeneca |
PLCO |
Jul 22, 2022 |
PLCO-991 |
| Identification of Risk Factors and Patient Populations at Risk for Developing Cancer of the Head and Neck |
Jay Piccirillo |
Washington University School of Medicine in St. Louis |
PLCO |
Jul 14, 2022 |
PLCO-1003 |
| Screening for ovarian cancer in women with a personal or family history of breast or ovarian cancer |
Nathan Bromham |
National Institute for Health and Care Excellence |
PLCO |
Jul 12, 2022 |
PLCO-1002 |
| Developing a multi-marker diagnostic test with predictive model enhancements for early-stage (Stage-1) Ovarian cancer |
Srinagesh Satyanarayana |
Kaya17 |
PLCO |
Jul 1, 2022 |
PLCO-1000 |
| Expanded Genome-Wide Association Study of Renal Cell Carcinoma |
Mark Purdue |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health |
PLCO |
Jul 1, 2022 |
PLCO-999 |
| Cancer risk prediction for self evaluation to create cancer awareness |
Loise Mwarangu |
Artificial Intelligence Center for Excellence |
PLCO |
Jul 1, 2022 |
PLCO-993 |
| Sharing PLCO oncoarray genotyping and covariate data with the African Ancestry Breast Cancer Consortium |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Jul 1, 2022 |
PLCO-1001 |
| Deep Predictive Clustering of Irregular Time Series Data for Prostate Cancer Risk and Its Explainability |
Vanessa Tschichold |
Norwegian University of Science and Technology |
PLCO |
Jun 24, 2022 |
PLCO-996 |
| Using Machine Learning algorithms to predict breast cancer in women, using Electronic Health Record information. |
Maya Carswell |
University Of Liverpool |
PLCO |
Jun 22, 2022 |
PLCO-994 |
| Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk |
Xuehong Zhang |
Harvard Medical School |
PLCO |
Jun 21, 2022 |
2022-0002 |
| Analysis of temporal dynamics of pro-inflammatory and anti-inflammatory cytokines during early evolution of ovarian endometrial and lung cancers |
Anna Lokshin |
University of Pittsburgh |
PLCO |
Jun 21, 2022 |
PLCO-992 |
